what are the 3 glp 1 drugs GLP-1 revolution: UAB researchers discovering about how these work Key Lessons for Ethical and
Description
doi: 10.1073/pnas.86.4.1367

If you have PCOS: You might need a bit more patience
Despite the limitations of the single-blind design in this clinical study, the advantages in exenatide-treated group in both cognitive and motor functions persisted in the follow-up study after a 12-mo wash-out period. 99 This suggests disease-modifying effects of exenatide, and the results are encouraging enough that a subsequent double-blind clinical study (NCT01971242) was initiated by the same investigators using a sustained release formulation of exenatide ( Bydureon : 2 mg administered subcutaneously once weekly) to evaluate in a similar group of PD subjects over a similar duration of time

But clinicians who offer it generally follow a pattern of starting low and titrating slowly based on how the patient responds

February 10, 2026
